Compare MPU & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPU | ELUT |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 46.5M |
| IPO Year | 2023 | 2020 |
| Metric | MPU | ELUT |
|---|---|---|
| Price | $0.85 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 55.8K | ★ 171.3K |
| Earning Date | 03-09-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ N/A | $1.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $0.50 |
| 52 Week High | $4.44 | $2.99 |
| Indicator | MPU | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 51.40 |
| Support Level | $0.77 | $0.89 |
| Resistance Level | $1.00 | $1.15 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 54.73 | 26.25 |
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.